Active Gastrointestinal Clinical Trials


Hepatocellular Carcinoma (liver Cancer)

Randomized Phase I/II, Multi-Center, Open-label PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinona

Colon/Colorectal Carcinoma

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of Enzastaurin with 5-FU/LV plus Bevacizumab as Maintenance Regimen Following First-Line Therapy for Metastatic Colorectal Cancer

Esophageal Carcinoma

Phase I Study of Concomitant Pemetrexed and CDDP Plus Radiation Therapy in Patients with Locally Advanced or Metastatic Esophageal or Gastroesophageal (GEJ) Carcinomas

Gastric Carcinoma (stomach cancer)

A Multicenter, Double-Blind, 3-Arm, Phase 1b/2 Study in Subjects with Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Adenocarcinoma to Evaluate the Safety and Efficacy of First-line Treatment with Epirubicin, Cisplatin, and Capecitabine(ECX) plus AMG 102

Carcinoid Tumors

A multicenter, randomized, blinded efficacy and safety study of pasireotide LAR vs octreotide LAR in patients with metastatic carcinoid tumors whose disease-related symptoms are inadequately controlled by somatostatin

Colon Cancer

S0820 A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III".